Regarding molecular mechanisms of interaction between chronic hepatitis and liver cancer, it has been reported that triggering the classical and non-classical NF-κB signaling pathways leads to the promotion of chronic hepatitis to liver cancer (79, 80), such as the lymphatic toxin, LTα1β2, which is significantly upregulated in liver cancer. This evidence concerns the gene NFKB1 and liver cancer.